-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Imax, Raises Price Target to $32

Benzinga·02/20/2025 22:29:38
Listen to the news
Barrington Research analyst Patrick Sholl maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $30 to $32.